Shingo Hotta, PHD
President & Director (Chair)
Shingo Hotta was appointed as the fourth President of the Ono Pharma Foundation in 2025 and is currently based on the Cambridge. He earned his Ph.D. in Pharmacy from Nagoya City University, Japan, in 2007.
Shingo began his distinguished career at Ono Pharmaceutical, where he contributed to the discovery of novel drug candidates and conducted signaling analyses in the field of oncology. Prior to joining the Ono Pharma Foundation, he played a pivotal role in planning and managing research collaborations with academic institutions, as well as overseeing drug discovery partnerships and licensing agreements with biotechnology companies at Ono Pharmaceutical in Japan, Ono Pharma USA, and Ono Pharma UK. Additionally, he has made significant contributions to the management of projects spanning from the discovery phase through to clinical development.
Drawing upon his extensive scientific expertise and his deep experience in fostering collaborations with academia and industry, Shingo dedicates to advancing innovative research and strengthening the scientific community. He is committed to accelerating the development of groundbreaking scientific solutions with the potential to transform patient care.